Member Info for unvrkw

Maybe today, the mologic tweet was positive In relation manufacturing of the Elisa test, who for we aren’t sure, volumes we aren’t sure hence Odx might update.

The IgG COVID19 ELISA is the first in a series of diagnostic tests @mologic have developed to support the pandemic response. The ELISA is currently being manufactured with @OmegaDiagnostic and we're pleased to see its development pathway is now published:

Well I’m assuming with mologic announcing the development path way for the Elisa test with Odx, being specific about manufacturing that this is a leading indicator of next step has been reached without them giving anything away that comes in an rns?

It’s an assumption that one piece of news leads to another. They are trying to validate Elisa with public health England, do they have to announce the development path way as part of this?

.

I don’t understand all the detail of the mologic tweet but any update by mologic in regards the Elisa test with Odx is good. This test is currently being evaluated by public health England in order to use and buy, Finncap put an estimated £15 to £30 million potentially in revenue behind it for Odx,

Now whether this update is prior an rns and this info needs to be published I don’t know. Elisa test is validating for uk market like the highlighted Roche test. The mologic POC test is separate from Odx and for developing markets, the point below covers both

In January, Mologic, embarked on a product development pathway for COVID-19 diagnostics focusing on ELISA and rapid diagnostic tests (RDTs), with anticipated funding from Wellcome Trust and DFID

after some pretty big sp increases so really i would suggest this is pretty steady overall and people are keen to invest. been a good week, wary it may of collapsed but i guess thats the risk everyone has in that they may walk away and the announcements drop!!! gla

they seem to spend the whole day dropping the sp down to find shares to obvioulsy sell to someone who has a price and then by day end take it back to where it needs to be based on sells and buys. at this rate we will be back around opening and whilst no great gain this is pretty good volume, stability in a share that has come on so far in the recent time and awaits some pretty meaty announcements coming

yes i can sell 100,000 shares on HL without a problem at just over 59p. not sure myself what this means, they want shares to then sell to someone else that has put an order and is waiting i assume? they dont of course buy shares for the sake of it. so someone likes this price, another day, loads of work i would think in the background and until announcements come out declaring all potential business for odx has gone elsewhere then they are i the game.

announcement on elisa, worth alot here and away from uk

announcement on poc here and away worth alot. wait until america implodes with too many cases, it will suck resource and tests from all over the world

colin will answer emails but of course colin will never give any insight to actually what is going on and rns announcements so there is no point asking. colin from my experience of where we are now is pretty shrewd and clear on what we are doing. if he isnt getting a uk deal he will be getting a foreign deal. i dont think either there will be a placing, last year he promised shareholders this wouldnt happen and i see no reason why now he would, i think they will find funding for stock and work going forward

They’ll be validating the test, talking volumes, access, price etc all being negotiated by government to try and create a deal. They had two weeks nearly head start on Roche for lab test so hopefully enough

Confirmed antibody tests will play a full role in the U.K. The Roche announcement just showed the potential out there. I think we will get the update on Elisa this week. Government will then announce this and continue to talk exit strategy.

This week will see more said about antibody tests and exit strategy so the risk to a non shareholder is that we get news soon, of course if we don't the so isn't now hugely overvalued anyway.

In a global market they will be able to sell a poc and Elisa lab test antibody, just too many customers would want a validated, accurate test. India for one where odx have many contacts, Australia likewise?

I don't think this margins are correct nor the volumes, I think it's mixed depending on which test you are talking about, they make far less poc tests per day than Elisa. Whatever the number it is good and likewise the margin.

I think once we have clarity on whether they are selling to U.K. Government we will discover whether they sell abroad, the U.K badge in science still stands for something

Odx margin average at the moment is around 66% based on the different tests they sell. The cd4 test belongs to them and the Burnett institute in Australia, odx have made it work to a manufacturing standard and had it passed to a cd4, 200 count level, no one else in the world for hiv has been able to do this in a poc test.

They make at least 50.000 tests possible on their Elisa setup for different tests, 100,000 poc tests per week in Scotland. So the margins are good but I would suggest pretty it would be pretty in sensitive to discuss openly at this time bearing in mind people are passing away.

Colin king has a good record and contacts, if he doesn't sell them in the U.K. I'm sure he will sell them world wide, this won't be a problem.

It’s an Elisa test which stands a good chance came from Odx and mologic. We all assume their doing nothing whereas they might now be selling huge numbers

Bear in mind this test from mologic also recieved suPorted government funding. Therefore we have a test gone forward to phe which has been supported by government. Stands a good chance!!

So USA FDA is now looking at tests that aren't good enough, most overall are lab tests And not poc tests that have the accuracy.

Matt Han**** mentioned Roche who he stated they were having discussions about large volumes but then also said this included other potential suppliers, test representative didn't mention roche and they have been working with odx and mologic for the last two weeks at least.

Poc obvious no one is anywhere near on having one as accurate as needed potential compared to U.K. And the RTC group, this if developed might be a global game changer as the FDA in USA also now tighten down.

And full confirmation antibody tests play a huge part in the future.

So the calculated punt on odx shares is, will the Elisa test for lab use get agreement?

Will the RTC make a poc test that works accurately enough and gets sign off?

EASY Decision?

Never seen the volume like this before and I don't know or understand the ins and outs of trading sharing in the background.

However loads of shares come through sandwiched within the 4th, huge number and surely if not declared, sales outweigh buys and so down but by end of the day they have to declare sending sp up. Leaving a gap as people who panicked thinking it a sell off followed suit?

Han**** mentioned Roche after the initial update on antibody tests. I'll wager all my shares that newspaper led and not from the detail work in the background.

John the test man said two tests being evaluated and they won't go Roche, completely the wrong message.

Plus then comment on poc coming along well, I think positive that antibody is now becoming a key agenda item

spent the whole day going up and down, whole day reading peoples reasons as to why its the end of the run and only one way down for odx, we get to the end of play and we are around 1 pence down!!!!

so has today all been about creating an sp dropping only to finish it off pretty much were we started??? wow, the rest of my portfolio dropped the same amount if not more today based on the latest corona position and economic problems.
so overall not too bad, 5 o'clock update which will no doubt walk more towards exit and what this included. full confidence in colin king ceo at odx that he will do whats right and realise as much value as possible in the best manner for odx. need to chill and wait for the elisa update then poc hopefully. gla

might get a bit closer towards the close?

interesting that the Roche update kinda spooks people with the assumption everything will go to them?

interesting how Roche publicise that they will produce millions of tests to supply which i would say is pretty positive demonstrating a demand?

so if the demand is there and Roche dont get it all then odx might get some?

we need to see soon whether Elisa is approved and accpeted by PHE meaning we can support uk tests instead of Roche. can we also supply abroad through odx or mologic?

second point we know a POC will do well especially if approved by PHE and validated by government!! so the risk is these things dont come off, the reward is they do and any update i think elisa anytime.

people lack paitence and willingness i guess to wait as they are keen to make a dollar and move on. i'm more interested in hopefully gaining over a longer period and i'm not dialling in and trading daily to make the faster buck.

the elisa approval the poc approval make a huge differance as everyone knows and thats the risk sitting in or coming out in the meantime between news. elisa i would be very surprised if not this week, poc anytime next two weeks as we already know they are working towards a BBI update from the ceo at the weekend. happy to hold see this one through. if they do 200k elisa tests per month and 400 k poc tests in june i think it would have been a good month!!!